论文部分内容阅读
近几年来我们在常规治疗基础上,应用善得定(北京诺华公司制造)治疗急性胰腺炎30例,取得了极满意的疗效。现报道如下。1 资料和方法1.1 病例选择 本组56例为1995年2月至1998年6月间住院患者,所有病例均急性起病。有上腹痛、压痛、返跳痛、肌紧张。血淀粉酶大于500U(苏氏法),尿淀粉酶大于1000U(苏氏法),或同时经超声、CT检查证实。所有病例均临床诊断急性胰腺炎明确。随机分成两组:善得定治疗组(以后称治疗组)30例,其中男13例,女17例,年龄18～67岁,平均46岁,非善得定治疗组(以后称对照组)26例,男12例,女14例,年龄20～68岁,平均46岁。
In recent years, we based on conventional treatment, the use of good set (Beijing Novartis company) in the treatment of 30 cases of acute pancreatitis, and achieved extremely satisfactory results. Report as follows now. 1 Materials and Methods 1.1 Case Selection 56 patients in this group for the period February 1995 to June 1998 inpatients, all cases were acute onset. Have abdominal pain, tenderness, back to jump pain, muscle tension. Blood amylase greater than 500U (SU’s method), urinary amylase greater than 1000U (SU’s method), or both by ultrasound, CT examination confirmed. All cases were clinically diagnosed with acute pancreatitis clear. Thirty patients were randomly divided into two groups: Shantouding treatment group (hereinafter referred to as treatment group), including 13 males and 17 females, aged from 18 to 67 years, with an average of 46 years. Non-Shantou treatment group (hereinafter referred to as the control group) 26 cases, 12 males and 14 females, aged 20 to 68 years, mean 46 years.